139 related articles for article (PubMed ID: 18625839)
1. Playing both sides: nucleophosmin between tumor suppression and oncogenesis.
Di Fiore PP
J Cell Biol; 2008 Jul; 182(1):7-9. PubMed ID: 18625839
[TBL] [Abstract][Full Text] [Related]
2. Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma.
Bonetti P; Davoli T; Sironi C; Amati B; Pelicci PG; Colombo E
J Cell Biol; 2008 Jul; 182(1):19-26. PubMed ID: 18625840
[TBL] [Abstract][Full Text] [Related]
3. The Nucleolar Protein GLTSCR2 Is an Upstream Negative Regulator of the Oncogenic Nucleophosmin-MYC Axis.
Kim JY; Cho YE; Park JH
Am J Pathol; 2015 Jul; 185(7):2061-8. PubMed ID: 25956029
[TBL] [Abstract][Full Text] [Related]
4. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
den Besten W; Kuo ML; Williams RT; Sherr CJ
Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
[TBL] [Abstract][Full Text] [Related]
5. Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation.
Li Z; Boone D; Hann SR
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18794-9. PubMed ID: 19033198
[TBL] [Abstract][Full Text] [Related]
6. Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription.
Li Z; Hann SR
Oncogene; 2013 Apr; 32(15):1988-94. PubMed ID: 22665062
[TBL] [Abstract][Full Text] [Related]
7. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
[TBL] [Abstract][Full Text] [Related]
8. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
[TBL] [Abstract][Full Text] [Related]
9. Reactivating the ARF-p53 axis in AML cells by targeting ULF.
Chen D; Yoon JB; Gu W
Cell Cycle; 2010 Aug; 9(15):2946-51. PubMed ID: 20699639
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation.
Kurki S; Peltonen K; Latonen L; Kiviharju TM; Ojala PM; Meek D; Laiho M
Cancer Cell; 2004 May; 5(5):465-75. PubMed ID: 15144954
[TBL] [Abstract][Full Text] [Related]
11. The Myc-nucleophosmin-ARF network: a complex web unveiled.
Li Z; Hann SR
Cell Cycle; 2009 Sep; 8(17):2703-7. PubMed ID: 19652540
[TBL] [Abstract][Full Text] [Related]
12. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effects of ginsenoside Rg1, cinnamic acid, and tanshinone IIA in osteosarcoma MG-63 cells: nuclear matrix downregulation and cytoplasmic trafficking of nucleophosmin.
Li QF; Shi SL; Liu QR; Tang J; Song J; Liang Y
Int J Biochem Cell Biol; 2008; 40(9):1918-29. PubMed ID: 18403247
[TBL] [Abstract][Full Text] [Related]
14. SIRT7-dependent deacetylation of NPM promotes p53 stabilization following UV-induced genotoxic stress.
Ianni A; Kumari P; Tarighi S; Simonet NG; Popescu D; Guenther S; Hölper S; Schmidt A; Smolka C; Yue S; Krüger M; Fiorillo C; Vaquero A; Bober E; Braun T
Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495326
[TBL] [Abstract][Full Text] [Related]
15. Nucleophosmin in leukemia: Consequences of anchor loss.
Brodská B; Šašinková M; Kuželová K
Int J Biochem Cell Biol; 2019 Jun; 111():52-62. PubMed ID: 31009764
[TBL] [Abstract][Full Text] [Related]
16. AML-associated mutation of nucleophosmin compromises its interaction with nucleolin.
Šašinková M; Holoubek A; Otevřelová P; Kuželová K; Brodská B
Int J Biochem Cell Biol; 2018 Oct; 103():65-73. PubMed ID: 30130654
[TBL] [Abstract][Full Text] [Related]
17. GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer.
Kim JY; Cho YE; An YM; Kim SH; Lee YG; Park JH; Lee S
J Cell Mol Med; 2015 Jun; 19(6):1245-52. PubMed ID: 25818168
[TBL] [Abstract][Full Text] [Related]
18. Nucleolar stress characterized by downregulation of nucleophosmin: a novel cause of neuronal degeneration.
Marquez-Lona EM; Tan Z; Schreiber SS
Biochem Biophys Res Commun; 2012 Jan; 417(1):514-20. PubMed ID: 22166220
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose Actinomycin-D Induces Redistribution of Wild-Type and Mutated Nucleophosmin Followed by Cell Death in Leukemic Cells.
Brodská B; Holoubek A; Otevřelová P; Kuželová K
J Cell Biochem; 2016 Jun; 117(6):1319-29. PubMed ID: 26505272
[TBL] [Abstract][Full Text] [Related]
20. Nucleolar phosphoprotein modifications as a marker of apoptosis induced by RITA treatment.
Wolfová K; Otevřelová P; Holoubek A; Brodská B
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119501. PubMed ID: 37276927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
